CClinicalTrials.gg
RecruitingNCT06355271MoFeUpdated Mar 16, 2026

Quality of Postoperative Analgesia and Functional Recovery After Elective Cesarean Delivery

An interventional study of Fentanyl 1 and Fentanyl2 in Obstetric Pain, sponsored by Ente Ospedaliero Cantonale, Bellinzona. Recruiting at 1 site in Switzerland. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-16.

Sponsored by Ente Ospedaliero Cantonale, Bellinzona · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 3 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
63
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Based on randomization, patients will receive a mixture for spinal anesthesia and will be followed in the following hours for the various outcomes and for functional recovery

Read the detailed description

In the study intervention group every patient will receive a spinal anesthesia composed by hyperbaric bupivacaine 12 mg 0,5 %, morphine sulfate 100 mcg and an added randomized dose of 10 or 20 mcg IT fentanyl. The spinal anesthetic will be administered with a 27 gauge Whitacre needle at the L2-3 or L3-4 intervertebral space with the patient in sitting position. Sterile saline will be used to dilute the mixture to a final volume of 3.1 mL. The allocated treatment will be kept a secret from the patient, the anesthesiologist managing the patient, and the entire study team. The fentanyl doses will be prepared by an anesthesiologist who will not be involved in the study or the patient's treatment. For 24 hours following surgery, each patient would receive intravenous patient-controlled morphine analgesia. In the control group every patient will receive a spinal anesthesia composed by hyperbaric bupivacaine 12 mg 0,5 % and morphine sulfate 100 mcg. The spinal anesthetic will be administered with a 27- gauge Whitacre needle at the L2-3 or L3-4 intervertebral space with the patient in sitting position. Sterile saline will be used to dilute the mixture to a final volume of 3.1 mL. The allocated treatment will be kept a secret from the patient, the anesthesiologist managing the patient, and the entire study team. For 24 hours following surgery, each patient would receive intravenous patient- controlled morphine analgesia.

02

Conditions studied

  • Obstetric Pain

Browse trials for

Keywords

  • Cesarean section
  • Fentanyl
  • Functional Recovery
03

In context

Labor Pain

396 studies on the registry are indexed under Labor Pain; 66 are open to participants now.

This study's planned enrollment of 63 is below the median of 100 across 325 interventional studies indexed under Labor Pain.

Browse Labor Pain studies →

Lead sponsor

Ente Ospedaliero Cantonale, Bellinzona is the lead sponsor of 37 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • patients over 18 year of age
  • height over 160 cm
  • American Society Anesthesiologists physical status I and II
  • term singleton parturients
  • scheduled for elective cesarean delivery during spinal anesthesia at Ospedale Regionale Bellinzona Valli

Exclusion criteria

Exclusion Criteria:

  • patients with inability to consent
  • patient refusal
  • contraindication to spinal anesthesia (eg, hemodynamic instability, infection at the surgery site, and neurologic defects such as transverse myelitis)
  • emergency cesarean delivery
  • preeclampsia/eclampsia
  • allergy to drugs used in the protocol
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
63 participants (estimated)

Study arms

  • Active comparator
    Control

    Spinal anesthesia with no fentanyl

    Procedure: Fentanyl 1

  • Experimental
    Experimental 1

    Spinal anesthesia with 10 mcg of fentanyl

    Procedure: Fentanyl2

  • Experimental
    Experimental 2

    Spinal anesthesia with 20 mcg of fentanyl

    Procedure: Fentanyl 3

Interventions

  • ProcedureFentanyl 1

    Spinal anesthesia with a 27- gauge Whitacre needle at the L2-3 or L3-4 intervertebral space with the patient in sitting position with hyperbaric bupivacaine 0,5 %12 mg, 100 mcg of morphine, and no fentanyl

  • ProcedureFentanyl2

    Spinal anesthesia with a 27- gauge Whitacre needle at the L2-3 or L3-4 intervertebral space with the patient in sitting position with hyperbaric bupivacaine 0,5 %12 mg, 100 mcg of morphine, and 10 mcg of of fentanyl

  • ProcedureFentanyl 3

    Spinal anesthesia with a 27- gauge Whitacre needle at the L2-3 or L3-4 intervertebral space with the patient in sitting position with hyperbaric bupivacaine 0,5 %12 mg, 100 mcg of morphine, and 20 mcg of fentanyl

06

What researchers measure

Primary outcomes

  1. Patient Controlled Analgesia morphine consumption

    Patient Controlled Analgesia morphine consumption in the first 24 postoperative hours

    Time frame: Day 1 after cesarean section

  2. obstetric quality of recovery score

    obstetric quality of recovery score (ObsQoR-11)

    Time frame: Day 1 after cesarean section

Secondary outcomes

  1. Visual Analogue Scale

    pain scores after surgery (Visual Analogue Scale -VAS- where 0 is the minimum value and 10 is the maximum value. The higher is the score the worse is pain control) at 4, 12 e 24 h.

    Time frame: Day 1 after cesarean section

  2. pruritus

    Intraoperative and postoperative pruritus (rating 0-10 The higher is the score the worse is pruritus)

    Time frame: Day 1 after cesarean section (and day 0 for intraoperative pruritus)

  3. nausea and vomiting; considering it as a dichotomous variable (yes or no), without evaluating its entity

    intraoperative and postoperative nausea and vomiting

    Time frame: Day 1 after cesarean section (and day 0 for intraoperative nausea and vomiting)

  4. intraoperative hypotension

    intraoperative hypotension

    Time frame: during the cesarean section

  5. intraoperative opioids

    intraoperative opioids in morphine equivalents

    Time frame: during the cesarean section

  6. satisfaction rate

    satisfaction rate (0-100, where 0 is the minimum value and 100 is the maximum value. The higher is the score the better is the satisfaction rate)

    Time frame: Day 1 after cesarean section

  7. intraoperative pain

    intraoperative pain Visual Analogue Scale (Visual Analogue Scale -VAS- where 0 is the minimum value and 10 is the maximum value. The higher is the score the worse is pain control)

    Time frame: during the surgery

07

Study locations

1 of 1 sites recruiting
  • Ospedale Regionale di Bellinzona, San Giovanni
    Bellinzona, Switzerland
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06355271
Lead sponsor
Ente Ospedaliero Cantonale, Bellinzona
Responsible party
Dossi Roberto (Dr. Med., Ente Ospedaliero Cantonale, Bellinzona) — Principal investigator
First posted
Apr 9, 2024
Start date
Jun 12, 2024
Primary completion
Dec 31, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Mar 16, 2026

Study contacts

Roberto Dossi
Contact
roberto.dossi@eoc.ch
0918119341
Alessandra Lauretta
Contact
alessandra.lauretta@eoc.ch
0918118182

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion